Which biotechnological process is essential for creating biopharmaceuticals from genetically modified organisms?

The process of genetic engineering is fundamental in the creation of biopharmaceuticals from genetically modified organisms. This method involves manipulating the genetic material of an organism to produce desired traits or products. In the context of biopharmaceuticals, genetic engineering allows scientists to insert genes that encode for therapeutic proteins—such as antibodies or hormones—into microorganisms or other host cells. Once these genetically modified organisms are cultivated, they can produce large quantities of the desired biopharmaceuticals through processes like fermentation.

Transcription does play a role in gene expression, as it is the process through which the genetic information in DNA is copied to produce RNA. However, this step does not specifically involve the initial creation or modification of organisms for pharmaceutical purposes.

Cell division is a natural biological process that occurs in all living organisms, including genetically modified ones, but it is not a targeted biotechnological process employed to create biopharmaceuticals.

Filtration is a separation technique used to purify products but doesn’t involve the engineering of organisms or the production of genetic material for pharmaceutical applications.

Thus, genetic engineering stands out as the essential process that directly enables the production of biopharmaceuticals from genetically modified organisms.